Serving MedTech, advanced manufacturing, and AI-enabled technology companies
Fractional CMO and CBO leadership, and project-based consulting for go-to-market, marketing strategy, and market expansion.
Yes. The engagement model depends on the objectives, scope, and internal capability.
Strategic planning, framework development, team guidance, performance metrics establishment, and regular executive-level check-ins aligned with your growth objectives.
Yes. Siraya Consultancy works alongside internal teams and external partners to provide alignment and direction.
When a product exists but traction, focus, or market direction is unclear, or when entering new markets requires strategic guidance.
Yes, particularly those with product-market fit ready to scale commercial operations or enter the U.S. market.
Startups, SMEs, and international firms in MedTech, HealthTech, medical device manufacturing, AI, and B2B technology markets.
(international companies: firms outside of United States)
Yes. We specialize in helping international companies, particularly from Asia, enter and expand in the U.S. market.
Start with an initial consultation to discuss objectives, challenges, and fit.
Business stage, objectives, key challenges, budget range, and expected timeline.
Typically within two to three weeks after scope and objectives are aligned.
Both. Onsite support is available per request, with remote collaboration for ongoing work.
U.S. Eastern Time (EST/EDT), with flexibility for different time zones.
Clients allocate the budget. Engagement scope and priorities are aligned within that budget.
Project-based work typically starts at four weeks. Fractional engagements usually begin at six months.
Terms and notice periods are defined upfront, with flexibility to adjust scope as business needs change.
Project-based consulting typically runs from four weeks to six months. Fractional leadership usually spans six months to one year or longer, depending on scope.
Yes. An initial consultation or short pilot can be used to assess fit before longer commitments.
Checkpoints are defined upfront. Results are assessed using agreed KPIs and structured analysis reports.
Common outcomes include clearer positioning, stronger pipelines, improved alignment, and more effective market entry.
“See-RYE-ah” (three syllables).
Yes. Experience includes medical devices and healthcare products.
Providing senior-level commercial and marketing direction to support growth and market entry.